Hassett says authors of New York Fed tariff study should be disciplined: ‘Worst paper I’ve ever seen’
The NEC director ripped the report, saying that central bank researchers ignored key aspects of how the duties worked
Calm S&P 500 performance masking historic turbulence in stocks so far this year
Don’t let the stock market’s relatively calm façade fool you. There are big moves taking place under the surface.
Here are Wednesday’s biggest analyst calls: Nvidia, Amazon, Palantir, Crocs, StubHub, Palo Alto Networks & more
Here are the biggest calls on Wall Street on Wednesday.
FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive
Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.
Meta CEO Mark Zuckerberg set to testify in LA social media safety trial
Meta CEO Mark Zuckerberg will take the stand in a closely watched social media and safety trial that could reshape the industry.
Oil jumps more than 2% after Vance says Iran ignored key U.S. demand, military strikes on the table
Oil traders are worried that war between the U.S. and Iran could lead to a major disruption of crude supplies in the Middle East.
U.S. FDA reverses course, will review Moderna’s modified flu vaccine application
Moderna said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine application, reversing an earlier decision.
Stocks making the biggest moves premarket: Nvidia, New York Times, Palantir & more
These are the stocks posting the largest moves in premarket trading.
Mizuho upgrades Palantir, says AI demand makes recent sell-off ‘unjustifiable’
Mizuho sees shares of Palantir rallying 47% from here.
The ‘boomcession’: Why Americans feel left behind by a growing economy
A combination of the words “boom” and “recession” can help explain why Americans feel so sour about a growing economy.